Trial Profile
Clinical Trials Insight: 700023834
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2007
Price :
$35
*
At a glance
- Drugs Pertuzumab (Primary)
- Indications Early breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 15 Jun 2007 New trial record.